In vitro maturation of immature oocytes for fertility preservation in cancer patients compared to control patients with fertility problems in an in vitro fertilization program

1Yeo W, Pang E, Liem GS, Suen JJS, Ng RYW, Yip CCH, et al. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors. Health Qual Life Outcomes 2020; 18: 24. doi: 10.1186/s12955-020-1283-xYeo W Pang E Liem GS Suen JJS Ng RYW Yip CCH et al Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors Health Qual Life Outcomes 2020 18 24 10.1186/s12955-020-1283-x701145432041627Open DOISearch in Google Scholar

2Silvestris E, Dellino M, Cafforio P, Paradiso AV, Cormio G, D'Oronzo S. Breast cancer: an update on treatment-related infertility. J Cancer Res Clin Oncol 2020; 146: 647-57. doi: 10.1007/s00432-020-03136-7Silvestris E Dellino M Cafforio P Paradiso AV Cormio G D'Oronzo S Breast cancer: an update on treatment-related infertility J Cancer Res Clin Oncol 2020 146 647 57 10.1007/s00432-020-03136-732006118Open DOISearch in Google Scholar

3Felicetti F, Castiglione A, Biasin E, Fortunati N, Dionisi-Vici M, Matarazzo P, et al. Effects of treatments on gonadal function in long-term survivors of pediatric hematologic malignancies: a cohort study. Pediatr Blood Cancer 2020; 67: e28709. doi: 10.1002/pbc.28709Felicetti F Castiglione A Biasin E Fortunati N Dionisi-Vici M Matarazzo P et al Effects of treatments on gonadal function in long-term survivors of pediatric hematologic malignancies: a cohort study Pediatr Blood Cancer 2020 67 e28709 10.1002/pbc.2870932918795Open DOISearch in Google Scholar

4Yeganeh L, Boyle JA, Gibson-Helm M, Teede H, Vincent AJ. Women's perspectives of early menopause: development of a word cloud. Climacteric 2020; 23: 417-20. doi: 10.1080/13697137.2020.1730318Yeganeh L Boyle JA Gibson-Helm M Teede H Vincent AJ Women's perspectives of early menopause: development of a word cloud Climacteric 2020 23 417 20 10.1080/13697137.2020.173031832124647Open DOISearch in Google Scholar

5Delattre S, Segers I, Van Moer E, Drakopoulos P, Mateizel I, Enghels L, et al. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study. Hum Reprod 2020; 35: 2524-36. doi: 10.1093/humrep/deaa193.Delattre S Segers I Van Moer E Drakopoulos P Mateizel I Enghels L et al Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study Hum Reprod 2020 35 2524 36 10.1093/humrep/deaa19332951035Open DOISearch in Google Scholar

6Dinas KD. Fertility counseling and preservation for breast cancer patients. Adv Exp Med Biol 2020; 1252: 181-87. doi: 10.1007/978-3-030-41596-9_25Dinas KD Fertility counseling and preservation for breast cancer patients Adv Exp Med Biol 2020 1252 181 87 10.1007/978-3-030-41596-9_2532816280Open DOISearch in Google Scholar

7Bénard J, Duros S, El Hachem H, Sonigo C, Sifer C, Grynberg M. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art. Future Oncol 2016; 12: 1731-41. doi: 10.2217/fon-2016-0095Bénard J Duros S El Hachem H Sonigo C Sifer C Grynberg M Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art Future Oncol 2016 12 1731 41 10.2217/fon-2016-009527184037Open DOISearch in Google Scholar

8de Pedro M, Otero B, Martín B. Fertility preservation and breast cancer: a review. Ecancer 2015; 9: 503. doi: 10.3332/ecancer.2015.503de Pedro M Otero B Martín B Fertility preservation and breast cancer: a review Ecancer 2015 9 503 10.3332/ecancer.2015.503433596325729416Open DOISearch in Google Scholar

9Kasum M, Beketić-Orešković L, Peddi PF, Orešković S, Johnson RH. Fertility after breast cancer treatment. Eur J Obstet Gynecol Reprod Biol 2014; 173: 13-8. doi: 10.1016/j.ejogrb.2013.11.009Kasum M Beketić-Orešković L Peddi PF Orešković S Johnson RH Fertility after breast cancer treatment Eur J Obstet Gynecol Reprod Biol 2014 173 13 8 10.1016/j.ejogrb.2013.11.00924315568Open DOISearch in Google Scholar

10Peccatori FA, Pup LD, Salvagno F, Guido M, Sarno MA, Revelli A, et al. Fertility preservation methods in breast cancer. Breast Care 2012; 7: 197202. doi: 10.1159/000339671Peccatori FA Pup LD Salvagno F Guido M Sarno MA Revelli A et al Fertility preservation methods in breast cancer Breast Care 2012 7 197202 10.1159/000339671340938822872792Open DOISearch in Google Scholar

11Redig AJ, Brannigan R, Stryker SJ, Woodruff TK, Jeruss JS. Incorporating fertility preservation into the care of young oncology patients. Cancer 2011; 117: 4-10. doi: 10.1002/cncr.25398Redig AJ Brannigan R Stryker SJ Woodruff TK Jeruss JS Incorporating fertility preservation into the care of young oncology patients Cancer 2011 117 4 10 10.1002/cncr.25398Open DOISearch in Google Scholar

12Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000; 169: 123-31. doi: 10.1016/s0303-7207(00)00365-8Meirow D Reproduction post-chemotherapy in young cancer patients Mol Cell Endocrinol 2000 169 123 31 10.1016/s0303-7207(00)00365-8Open DOISearch in Google Scholar

13Specchia C, Baggiani A, Immediata V, Ronchetti C, Cesana A, Smeraldi A, et al. Oocyte cryopreservation in oncological patients: eighteen years’ experience of a tertiary care referral center. Front Endocrinol 2019; 10: 600. doi: 10.3389/fendo.2019.00600Specchia C Baggiani A Immediata V Ronchetti C Cesana A Smeraldi A et al Oocyte cryopreservation in oncological patients: eighteen years’ experience of a tertiary care referral center Front Endocrinol 2019 10 600 10.3389/fendo.2019.00600673391331551931Open DOISearch in Google Scholar

14Gook DA, Edgar DH. Cryopreservation of female reproductive potential. Best Pract Res Clin Obstet Gynaecol 2019; 55: 23-36. doi: 10.1016/j.bpobgyn.2018.08.005Gook DA Edgar DH Cryopreservation of female reproductive potential Best Pract Res Clin Obstet Gynaecol 2019 55 23 36 10.1016/j.bpobgyn.2018.08.00530249473Open DOISearch in Google Scholar

15Cobo A, García-Velasco J, Domingo J, Pellicer A, Remohí J. Elective and oncofertility preservation: factors related to IVF outcomes. Hum Reprod 2018; 33: 2222-31. doi: 10.1093/humrep/dey321Cobo A García-Velasco J Domingo J Pellicer A Remohí J Elective and oncofertility preservation: factors related to IVF outcomes Hum Reprod 2018 33 2222 31 10.1093/humrep/dey32130383235Open DOISearch in Google Scholar

16Dolmans MM, Donnez J. Fertility preservation in women for medical and social reasons: oocytes vs ovarian tissue. Best Pract Res Clin Obstet Gynaecol 2020; 21: S1521-6934(20)30122-X. doi: 10.1016/j.bpobgyn.2020.06.011Dolmans MM Donnez J Fertility preservation in women for medical and social reasons: oocytes vs ovarian tissue Best Pract Res Clin Obstet Gynaecol 2020 21 S1521 6934 (20)30122-X 10.1016/j.bpobgyn.2020.06.01132800711Open DOISearch in Google Scholar

17Khalili MA, Shahedi A, Ashourzadeh S, Nottola SA, Macchiarelli G, Palmerini MG. Vitrification of human immature oocytes before and after in vitro maturation: a review. J Assist Reprod Genet 2017; 34: 1413-26. doi: 10.1007/s10815-017-1005-4Khalili MA Shahedi A Ashourzadeh S Nottola SA Macchiarelli G Palmerini MG Vitrification of human immature oocytes before and after in vitro maturation: a review J Assist Reprod Genet 2017 34 1413 26 10.1007/s10815-017-1005-4569998628822010Open DOISearch in Google Scholar

18Ata B, Chian RC, Tan SL. Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Res Clin Obstet Gynaecol 2010; 24: 101-12. doi: 10.1016/j.bpobgyn.2009.11.007Ata B Chian RC Tan SL Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients Best Pract Res Clin Obstet Gynaecol 2010 24 101 12 10.1016/j.bpobgyn.2009.11.00720116335Open DOISearch in Google Scholar

19El Hachem H, Atallah D, Grynberg M. Fertility preservation in breast cancer patients. Future Oncol 2014; 10: 1767-77. doi: 10.2217/fon.14.55El Hachem H Atallah D Grynberg M Fertility preservation in breast cancer patients Future Oncol 2014 10 1767 77 10.2217/fon.14.5525303056Open DOISearch in Google Scholar

20Muñoz E, Domingo J, De Castro G, Lorenzo I, García-Velasco JA, Bellver J, et al. Ovarian stimulation for oocyte vitrification does not modify disease-free survival and overall survival rates in patients with early breast cancer. Reprod Biomed Online 2019; 39: 860-67. doi: 10.1016/j.rbmo.2019.07.003Muñoz E Domingo J De Castro G Lorenzo I García-Velasco JA Bellver J et al Ovarian stimulation for oocyte vitrification does not modify disease-free survival and overall survival rates in patients with early breast cancer Reprod Biomed Online 2019 39 860 67 10.1016/j.rbmo.2019.07.00331564650Open DOISearch in Google Scholar

21Rodgers RJ. Fertility preservation in breast cancer patients. Minerva Ginecol 2019; 71: 196-206. doi: 10.23736/S0026-4784.19.04409-5Rodgers RJ Fertility preservation in breast cancer patients Minerva Ginecol 2019 71 196 206 10.23736/S0026-4784.19.04409-531089071Open DOISearch in Google Scholar

22Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Hum Reprod 2016; 31: 623-9. doi: 10.1093/humrep/dev325Grynberg M Poulain M le Parco S Sifer C Fanchin R Frydman N Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients Hum Reprod 2016 31 623 9 10.1093/humrep/dev32526759139Open DOISearch in Google Scholar

23Grynberg M, Mayeur Le Bras A, Hesters L, Gallot V, Frydman N. First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer. Ann Oncol 2020; 31: 541-42. doi: 10.1016/j.annonc.2020.01.005Grynberg M Mayeur Le Bras A Hesters L Gallot V Frydman N First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer Ann Oncol 2020 31 541 42 10.1016/j.annonc.2020.01.00532085890Open DOISearch in Google Scholar

24World Health Organisation. WHO laboratory manual for the examination and processing of human semen. Geneva: WHO Press; 2010.World Health Organisation WHO laboratory manual for the examination and processing of human semen Geneva WHO Press 2010Search in Google Scholar

25Stimpfel M, Vrtacnik-Bokal E, Virant-Klun I. No difference in mitochondrial distribution is observed in human oocytes after cryopreservation. Arch Gynecol Obstet 2017; 296: 373-81. doi: 10.1007/s00404-017-4428-3Stimpfel M Vrtacnik-Bokal E Virant-Klun I No difference in mitochondrial distribution is observed in human oocytes after cryopreservation Arch Gynecol Obstet 2017 296 373 81 10.1007/s00404-017-4428-328631074Open DOISearch in Google Scholar

26Virant-Klun I, Bauer C, Ståhlberg A, Kubista M, Skutella T. Human oocyte maturation in vitro is improved by co-culture with cumulus cells from mature oocytes. Reprod Biomed Online 2018; 36: 508-23. doi: 10.1016/j.rbmo.2018.01.011Virant-Klun I Bauer C Ståhlberg A Kubista M Skutella T Human oocyte maturation in vitro is improved by co-culture with cumulus cells from mature oocytes Reprod Biomed Online 2018 36 508 23 10.1016/j.rbmo.2018.01.01129503212Open DOISearch in Google Scholar

27Stimpfel M, Verdenik I, Zorn B, Virant-Klun I. Magnetic-activated cell sorting of non-apoptotic spermatozoa improves the quality of embryos according to female age: a prospective sibling oocyte study. J Assist Reprod Genet 2018; 35: 1665-74. doi:10.1007/s10815-018-1242-1Stimpfel M Verdenik I Zorn B Virant-Klun I Magnetic-activated cell sorting of non-apoptotic spermatozoa improves the quality of embryos according to female age: a prospective sibling oocyte study J Assist Reprod Genet 2018 35 1665 74 10.1007/s10815-018-1242-1613381229946759Open DOISearch in Google Scholar

28ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine. The Vienna consensus: report of an expert meeting on the development of art laboratory performance indicators. Hum Reprod Open 2017; 2017: 1-17. doi: 10.1093/hropen/hox011ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine The Vienna consensus: report of an expert meeting on the development of art laboratory performance indicators Hum Reprod Open 2017 2017 1 17 10.1093/hropen/hox011627664931486806Open DOISearch in Google Scholar

29Lefebvre T, Mirallié S, Leperlier F, Reignier A, Barrière P, Fréour T. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type. Reprod Biomed Online 2018; 37: 201-7. doi: 10.1016/j.rbmo.2018.04.047Lefebvre T Mirallié S Leperlier F Reignier A Barrière P Fréour T Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type Reprod Biomed Online 2018 37 201 7 10.1016/j.rbmo.2018.04.04729784618Open DOISearch in Google Scholar

30Nordan T, Thomas AM, Ginsburg ES, Wen PY, Dolinko AV, Bortoletto P. Fertility preservation outcomes in women with gliomas: a retrospective case-control study. J Neurooncol 2020; 147: 371-76. doi: 10.1007/s11060-020-03429-4Nordan T Thomas AM Ginsburg ES Wen PY Dolinko AV Bortoletto P Fertility preservation outcomes in women with gliomas: a retrospective case-control study J Neurooncol 2020 147 371 76 10.1007/s11060-020-03429-432060839Open DOISearch in Google Scholar

31Malacarne E, Devesa M, Martinez F, Rodriguez I, Coroleu B. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age. J Assist Reprod Genet 2020; 37: 3069-76. doi: 10.1007/s10815-020-01944-xMalacarne E Devesa M Martinez F Rodriguez I Coroleu B COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age J Assist Reprod Genet 2020 37 3069 76 10.1007/s10815-020-01944-x771481832945994Open DOISearch in Google Scholar

32Grynberg M, Dagher Hayeck B, Papanikolaou EG, Sifer C, Sermondade N, Sonigo C. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro. Hum Reprod 2019; 34: 374-79. doi: 10.1093/humrep/dey358Grynberg M Dagher Hayeck B Papanikolaou EG Sifer C Sermondade N Sonigo C BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro Hum Reprod 2019 34 374 79 10.1093/humrep/dey35830561604Open DOISearch in Google Scholar

33Gunnala V, Fields J, Irani M, D'Angelo D, Xu K, Schattman G, et al. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation. Fertil Steril 2019; 111: 363-71. doi: 10.1016/j.fertnstert.2018.10.014Gunnala V Fields J Irani M D'Angelo D Xu K Schattman G et al BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation Fertil Steril 2019 111 363 71 10.1016/j.fertnstert.2018.10.01430527950Open DOISearch in Google Scholar

34Moria A, Das M, Shehata F, Holzer H, Son WY, Tulandi T. Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment. Fertil Steril 2011; 95: 1621-3. doi: 10.1016/j.fertnstert.2010.12.041Moria A Das M Shehata F Holzer H Son WY Tulandi T Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment Fertil Steril 2011 95 1621 3 10.1016/j.fertnstert.2010.12.04121236421Open DOISearch in Google Scholar

35Volodarsky-Perel A, Cai E, Tulandi T, Son WY, Suarthana E, Buckett W. Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women. Reprod Biomed Online 2020; 40: 215-22. doi: 10.1016/j.rbmo.2019.11.006Volodarsky-Perel A Cai E Tulandi T Son WY Suarthana E Buckett W Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women Reprod Biomed Online 2020 40 215 22 10.1016/j.rbmo.2019.11.00631953011Open DOISearch in Google Scholar

36Balayla J, Tulandi T, Buckett W, Holzer H, Steiner N, Shrem G, et al. Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles. J Assist Reprod Genet 2020; 37: 913-21. doi: 10.1007/s10815-020-01730-9Balayla J Tulandi T Buckett W Holzer H Steiner N Shrem G et al Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles J Assist Reprod Genet 2020 37 913 21 10.1007/s10815-020-01730-9718302632144524Open DOISearch in Google Scholar

37Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online 2010; 21: 566-71. doi: 10.1016/j.rbmo.2010.05.003Shalom-Paz E Almog B Shehata F Huang J Holzer H Chian RC et al Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification Reprod Biomed Online 2010 21 566 71 10.1016/j.rbmo.2010.05.00320822957Open DOISearch in Google Scholar

38Liu Z, Liang G, Tan L, Su AN, Jiang W, Gong C. High-efficient screening method for identification of key genes in breast cancer through microarray and bioinformatics. Anticancer Res 2017; 37: 4329-35. doi: 10.21873/anticanres.11826Liu Z Liang G Tan L Su AN Jiang W Gong C High-efficient screening method for identification of key genes in breast cancer through microarray and bioinformatics Anticancer Res 2017 37 4329 35 10.21873/anticanres.1182628739725Open DOISearch in Google Scholar

39Cohen Y, Tannus S, Volodarsky-Perel A, Son WY, Tulandi T, Buckett W. Added benefit of immature oocyte maturation for fertility preservation in women with malignancy. Reprod Sci 2020; 27: 2257-64. doi: 10.1007/s43032-020-00245-zCohen Y Tannus S Volodarsky-Perel A Son WY Tulandi T Buckett W Added benefit of immature oocyte maturation for fertility preservation in women with malignancy Reprod Sci 2020 27 2257 64 10.1007/s43032-020-00245-z32617879Open DOISearch in Google Scholar

40Chatroudi MH, Khalili MA, Ashourzadeh S, Anbari F, Shahedi A, Safari S. Growth differentiation factor 9 and cumulus cell supplementation in in vitro maturation culture media enhances the viability of human blastocysts. Clin Exp Reprod Med 2019; 46: 166-72. doi: 10.5653/cerm.2019.00402Chatroudi MH Khalili MA Ashourzadeh S Anbari F Shahedi A Safari S Growth differentiation factor 9 and cumulus cell supplementation in in vitro maturation culture media enhances the viability of human blastocysts Clin Exp Reprod Med 2019 46 166 72 10.5653/cerm.2019.00402691920631813208Open DOISearch in Google Scholar

41Sacha CR, Kaser DJ, Farland LV, Srouji S, Missmer SA, Racowsky C. The effect of short-term exposure of cumulus-oocyte complexes to in vitro maturation medium on yield of mature oocytes and usable embryos in stimulated cycles. J Assist Reprod Genet 2018; 35: 841-49. doi: 10.1007/s10815-018-1155-zSacha CR Kaser DJ Farland LV Srouji S Missmer SA Racowsky C The effect of short-term exposure of cumulus-oocyte complexes to in vitro maturation medium on yield of mature oocytes and usable embryos in stimulated cycles J Assist Reprod Genet 2018 35 841 49 10.1007/s10815-018-1155-z598489329536383Open DOISearch in Google Scholar

42Pongsuthirak P, Songveeratham S, Vutyavanich T. Comparison of blastocyst and Sage media for in vitro maturation of human immature oocytes. Reprod Sci 2015; 22: 343-6. doi: 10.1177/1933719114542027Pongsuthirak P Songveeratham S Vutyavanich T Comparison of blastocyst and Sage media for in vitro maturation of human immature oocytes Reprod Sci 2015 22 343 6 10.1177/1933719114542027435214325015901Open DOISearch in Google Scholar

43Junk SM, Yeap D. Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome. Fertil Steril 2012; 98: 888-92. doi: 10.1016/j.fertnstert.2012.06.055Junk SM Yeap D Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome Fertil Steril 2012 98 888 92 10.1016/j.fertnstert.2012.06.05522835445Open DOISearch in Google Scholar

44Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online 2010; 20: 634-8. doi: 10.1016/j.rbmo.2010.01.012Oktay K Buyuk E Rodriguez-Wallberg KA Sahin G In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation Reprod Biomed Online 2010 20 634 8 10.1016/j.rbmo.2010.01.01220219430Open DOISearch in Google Scholar

45D'Hondt C, Vanhoeij M, Van Moer E, Segers I, Fontaine C, Tournaye H, et al. Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy. Breast Cancer Res Treat 2020; 184: 433-44. doi: 10.1007/s10549-020-05858-1D'Hondt C Vanhoeij M Van Moer E Segers I Fontaine C Tournaye H et al Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy Breast Cancer Res Treat 2020 184 433 44 10.1007/s10549-020-05858-132794060Open DOISearch in Google Scholar

46Huang JY, Chian RC, Gilbert L, Fleiszer D, Holzer H, Dermitas E, et al. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients. Am J Surg 2010; 200: 177-83. doi: 10.1016/j.amjsurg.2009.04.004Huang JY Chian RC Gilbert L Fleiszer D Holzer H Dermitas E et al Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients Am J Surg 2010 200 177 83 10.1016/j.amjsurg.2009.04.00420637351Open DOISearch in Google Scholar

47Oktay K, Demirtas E, Son WY, Lostritto K, Chian RC, Tan SL. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Fertil Steril 2008; 89: 228.e19-22. doi: 10.1016/j.fertnstert.2007.02.028Oktay K Demirtas E Son WY Lostritto K Chian RC Tan SL In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation Fertil Steril 2008 89 228 e19-22 10.1016/j.fertnstert.2007.02.02817517403Open DOISearch in Google Scholar

48Marklund A, Eloranta S, Wikander I, Kitlinski ML, Lood M, Nedstrand E, et al. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study. Hum Reprod 2020; 35: 929-38. doi: 10.1093/humrep/deaa029Marklund A Eloranta S Wikander I Kitlinski ML Lood M Nedstrand E et al Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study Hum Reprod 2020 35 929 38 10.1093/humrep/deaa029719253232313940Open DOISearch in Google Scholar

49American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 2019; 112: 1022-33. doi: 10.1016/j.fertnstert.2019.09.013American Society for Reproductive Medicine Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 2019 112 1022 33 10.1016/j.fertnstert.2019.09.01331843073Open DOISearch in Google Scholar

50Rose BI, Brown SE. A review of the physiology behind letrozole applications in infertility: are current protocols optimal? J Assist Reprod Genet 2020; 37: 2093-104. doi: 10.1007/s10815-020-01892-6Rose BI Brown SE A review of the physiology behind letrozole applications in infertility: are current protocols optimal? J Assist Reprod Genet 2020 37 2093 104 10.1007/s10815-020-01892-6749229832712844Open DOISearch in Google Scholar

51Santiquet NW, Greene AF, Becker J, Barfield JP, Schoolcraft WB, Krisher RL. A pre-in vitro maturation medium containing cumulus oocyte complex ligand-receptor signaling molecules maintains meiotic arrest, supports the cumulus oocyte complex and improves oocyte developmental competence. Mol Hum Reprod 2017; 23: 594-606. doi: 10.1093/molehr/gax032Santiquet NW Greene AF Becker J Barfield JP Schoolcraft WB Krisher RL A pre-in vitro maturation medium containing cumulus oocyte complex ligand-receptor signaling molecules maintains meiotic arrest, supports the cumulus oocyte complex and improves oocyte developmental competence Mol Hum Reprod 2017 23 594 606 10.1093/molehr/gax03228586460Open DOISearch in Google Scholar

52Walls ML, Hunter T, Ryan JP, Keelan JA, Nathan E, Hart RJ. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum Reprod 2015; 30: 88-96. doi: 10.1093/humrep/deu248Walls ML Hunter T Ryan JP Keelan JA Nathan E Hart RJ In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes Hum Reprod 2015 30 88 96 10.1093/humrep/deu24825355587Open DOISearch in Google Scholar

53Walls ML, Hart R, Keelan JA, Ryan JP. Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization. Fertil Steril 2016; 106: 1392-98. doi: 10.1016/j.fertnstert.2016.08.014Walls ML Hart R Keelan JA Ryan JP Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization Fertil Steril 2016 106 1392 98 10.1016/j.fertnstert.2016.08.01427565256Open DOISearch in Google Scholar

54Roesner S, Dietrich JE, Weigert J, Montag M, Toth B, Strowitzki T. Time-lapse imaging reveals differences in growth dynamics of embryos after in vitro maturation compared with conventional stimulation. Fertil Steril 2017; 107: 606-12. doi: 10.1016/j.fertnstert.2016.12.026Roesner S Dietrich JE Weigert J Montag M Toth B Strowitzki T Time-lapse imaging reveals differences in growth dynamics of embryos after in vitro maturation compared with conventional stimulation Fertil Steril 2017 107 606 12 10.1016/j.fertnstert.2016.12.02628139236Open DOISearch in Google Scholar

55Belva F, Roelants M, Vermaning S, Desmyttere S, De Schepper J, Bonduelle M, et al. Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome. Hum Reprod Open 2020; 2020: hoz043. doi: 10.1093/hropen/hoz043Belva F Roelants M Vermaning S Desmyttere S De Schepper J Bonduelle M et al Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome Hum Reprod Open 2020 2020: hoz043 10.1093/hropen/hoz043700912232055712Open DOISearch in Google Scholar

56Yu EJ, Yoon TK, Lee WS, Park EA, Heo JY, Ko YK, et al. Obstetrical, neonatal, and long-term outcomes of children conceived from in vitro matured oo-cytes. Fertil Steril 2019; 112: 691-99. doi: 10.1016/j.fertnstert.2019.05.034Yu EJ Yoon TK Lee WS Park EA Heo JY Ko YK et al Obstetrical, neonatal, and long-term outcomes of children conceived from in vitro matured oo-cytes Fertil Steril 2019 112 691 99 10.1016/j.fertnstert.2019.05.03431371040Open DOISearch in Google Scholar

57Son WY, Henderson S, Cohen Y, Dahan M, Buckett W. Immature Oocyte for Fertility Preservation. Front Endocrinol 2019; 10: 464. doi: 10.3389/fendo.2019.00464Son WY Henderson S Cohen Y Dahan M Buckett W Immature Oocyte for Fertility Preservation Front Endocrinol 2019 10 464 10.3389/fendo.2019.00464665052631379739Open DOISearch in Google Scholar

58Shirasawa H, Terada Y. In vitro maturation of human immature oocytes for fertility preservation and research material. Reprod Med Biol 2017; 16: 25867. doi: 10.1002/rmb2.12042Shirasawa H Terada Y In vitro maturation of human immature oocytes for fertility preservation and research material Reprod Med Biol 2017 16 25867 10.1002/rmb2.12042571588129259476Open DOISearch in Google Scholar